Association between Polymorphisms of rs3924999, rs35753505 in NRG1 Gene and the Efficacy of Risperidone in Patients with Schizophrenia

Lin Yuan Yuan; Yuan Jing; Zeng Lei; Wei Yu Jun; Zhang Yan; Xu Li; Yang Jian Zhong

Article Contents

Article Navigation > Journal of Kunming Medical University > 2018 > 39(06): 76-81

Lin Yuan Yuan , Yuan Jing , Zeng Lei , Wei Yu Jun , Zhang Yan , Xu Li , Yang Jian Zhong . Association between Polymorphisms of rs3924999, rs35753505 in NRG1 Gene and the Efficacy of Risperidone in Patients with Schizophrenia[J]. Journal of Kunming Medical University, 2018, 39(06): 76-81.

Citation:

Lin Yuan Yuan , Yuan Jing , Zeng Lei , Wei Yu Jun , Zhang Yan , Xu Li , Yang Jian Zhong . Association between Polymorphisms of rs3924999, rs35753505 in NRG1 Gene and the Efficacy of Risperidone in Patients with Schizophrenia[J]. Journal of Kunming Medical University, 2018, 39(06): 76-81.

Citation:

Lin Yuan Yuan , Yuan Jing , Zeng Lei , Wei Yu Jun , Zhang Yan , Xu Li , Yang Jian Zhong . Association between Polymorphisms of rs3924999, rs35753505 in NRG1 Gene and the Efficacy of Risperidone in Patients with Schizophrenia[J]. Journal of Kunming Medical University, 2018, 39(06): 76-81.

PDF( 265 KB)

Association between Polymorphisms of rs3924999, rs35753505 in NRG1 Gene and the Efficacy of Risperidone in Patients with Schizophrenia

Funds:

基金：国家自然科学基金资助项目 (81160170);

Received Date: 2018-02-11

Abstract

Abstract

Objective To investigate the association between polymorphisms of rs35753505, rs3924999 in neuregulin-1 (NRG1) gene and the efficacy of risperidone after 12 weeks treatment in Han patients with schizophrenia from Yunnan of China.Me thods A case-control study was conducted: 114 schizophrenic Han inpatients with 12 weeks single therapy of risperidone were randomly selected from July 2012 to March 2013 and 187 normal Han persons whose age and years of education matched the controls.Taq Man allelic genotyping technology was used to analyze NRG1 genotyping.Treatment effect of risperidone was evaluated by the positive and negative symptoms scale (PANSS) , PSP, Raven's Standard Progressive Matrices, Wechsler Intelligence Scale and Number Cancellation Test.Re s ults (1) There was no statistically difference in genotypes, allele frequencies of rs35753505, rs3924999 polymorphic locibetween schizophrenic inpatients and normal persons. (2) The baseline clinical data of patients with schizophrenia in different NRG1 gene polymorphism was not significant. (3) The value difference of Number Cancellation Test One between pre and post treatment of risperidone was related with different genotypes of two polymorphismsin NRG1 gene, there was statistically difference in two genotypes of rs35753505 loci: G/A group was higher than G/G group (P = 0.010) and in three genotypes of rs3924999 loci: A/A group was higher than A/G group (P = 0.032) . (4) The value difference of Reven's Standard Progressive Matrices between pre and post treatment of risperidone was related with rs35753505 polymorphic loci: G/A group was higher than G/G group (P = 0.004) (5) The result of correlation regression analysis between pre and post treatment of risperidone showed that the value difference of Number Cancellation Test Two was related with the baseline clinical data of course, dose, immediate memory, net score of Number Cancellation Test Two, Number Cancellation Test Three and the genotypes of rs35753505 loci.Conclus ion After 12 weeks treatment of risperidone: the improvement degree of patients' attention directivity and concentrated force in different genotypes of rs35753505 loci was different:G/A group was higher than G/G group.
- Schizophrenia,
- Neuregulin-1 (NRG1) ,
- Risperidone,
- Association study

FullText(HTML)

References(28)

References

[1]	[1]KUROKI T, NAGAO N, NAKAHARA T.Neuropharmacology of second-generation antipsychotic drugs:a validity of the serotonin-dopamine hypothesis[J].Prog Brain Res, 2008, 172 (5) :199-212.
[2]蔡文婷, 谢莹, 肖剑文, 等.盐酸齐拉西酮片与利培酮治疗精神分裂症的疗效及安全性的对比分析[J].当代医学, 2017, 23 (04) :108-109.
[3]高良会, 王健, 孙秀丽, 等.比较氨磺必利与利培酮治疗精神分裂症的疗效与安全性[J].中国临床药理学杂志, 2013, 29 (09) :653-655.
[4]范小冬, 谢星星, 张杰, 等.齐拉西酮与利培酮治疗首发精神分裂症疗效与安全性的系统评价[J].川北医学院学报, 2017, 32 (02) :197-201.
[5]	[5]HARRISON P J, LAW A J.Neuregulin 1 and schizophrenia:genetics, gene expression, and neurobiology[J].Biol Psychiatry, 2006, 60 (2) :132-140.
[6]	[6]MEI L, NAVE K A.Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases[J].Neuron, 2014, 83 (1) :27-49.
[7]	[7] MEI L, XIONG W C.Neuregulin 1 in neural development, synaptic plasticity and schizophrenia[J].Nat Rev Neurosci, 2008, 9 (6) :437-452.
[8]	[8]FALLS D L.Neuregulins:functions, forms, and signaling strategies[J].Exp Cell Res, 2003, 284 (1) :14-30.
[9]	[9]STEFANSSON H, SIGURDSSON E, STEINTHORSDOTTIR V, et al.neuregulin 1 and susceptibility to schizophrenia[J].Am J Hum Genet, 2002, 71 (4) :877-892.
[10]师乐, 李素霞, 邓佳慧, 等.《精神障碍诊断与统计手册》第5版中谱系障碍的变化[J].中国神经精神疾病杂志, 2015, 41 (04) :253-256.
[11]	[11]KAY S R, FISZBEIN A, OPLER L A.The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia[J].Schizophrenia Bulletin, 1987, 13 (2) :261.
[12]侯晓君.小鼠前额叶皮层和丘脑网状核γ-氨基丁酸能神经环路的调控及其机制[D].杭州:浙江大学博士学位论文, 2014.
[13]	[13]STEFANSSON H, SARGINSON J, KONG A, et al.association of neuregulin 1 with schizophrenia confirmed in a scottish population[J].Am J Hum Genet, 2003, 72 (1) :83-87.
[14]	[14]AGIM Z S, ESENDAL M, BRIOLLAIS L, et al.Discovery, validation and characterization of Erbb4 and Nrg1haplotypes using data from three genome-wide association studies of schizophrenia[J].PLo S One, 2013, 8 (1) :e53042.
[15]	[15]LAW A J, WANG Y, SEI Y, et al.Neuregulin1-Erb B4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110delta inhibition as a potential therapeutic strategy[J].Proc Natl Acad Sci U S A, 2012, 109 (30) :12165-12170.
[16]	[16]PAPALEO F, YANG F, PATERSON C, et al.Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model[J].J Neurosci, 2016, 36 (17) :4859-4875.
[17]唐君霞.DTNBP1和NRG1基因是中国汉族人群精神分裂症的易感基因[D].上海:中国科学院研究生院 (上海生命科学研究院) 博士学位论文, 2003.
[18]	[18]LI D, COLLIER D A, HE L.Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia[J].Hum Mol Genet, 2006, 15 (12) :1995-2002.
[19]	[19]KRUG A, MARKOV V, EGGERMANN T, et al.Genetic variation in the schizophrenia-risk gene neuregulin1 correlates with differences in frontal brain activation in a working memory task in healthy individuals[J].Neuroimage, 2008, 42 (4) :1569-1576.
[20]	[20]THIRUNAVUKKARASU P, VIJAYAKUMARI A A, JOHN J P, et al.An exploratory association study of the influence of dysbindin and neuregulin polymorphisms on brain morphometry in patients with schizophrenia and healthy subjects from South India[J].Asian Journal of Psychiatry, 2014, 10 (5) :62-68.
[21]	[21]MOSTAID M S, MANCUSO S G, LIU C, et al.Meta-analysis reveals associations between genetic variation in the 5'and 3'regions of Neuregulin-1 and schizophrenia[J].Transl Psychiatry, 2017, 7 (1) :e1004.
[22]	[22]LIN H F, LIU Y L, LIU C M, et al.Neuregulin 1 gene and variations in perceptual aberration of schizotypal personality in adolescents[J].Psychol Med, 2005, 35 (11) :1589-1598.
[23]	[23]HE B S, ZHANG L Y, PAN Y Q, et al.Association of the DISC1 and NRG1 genetic polymorphisms with schizophrenia in a Chinese population[J].Gene, 2016, 590 (2) :293-297.
[24]胡晓虹.精神分裂症与NRG1基因多态位点rs3924999的传递不平衡研究[D].汕头:汕头大学硕士学位论文, 2006.
[25]	[25]NAWAZ R, ASIF H, KHAN A, et al.Drugs targeting SNPrs35753505 of the NRG1 gene may prevent the association of neurological disorder schizophrenia in a Pakistani population[J].CNS Neurol Disord Drug Targets, 2014, 13 (9) :1604-1614.
[26]	[26]KANG C, YANG X, XU X, et al.Association study of neuregulin 1 gene polymorphisms with auditory P300 in schizophrenia[J].Am J Med Genet B Neuropsychiatr Genet, 2012, 159B (4) :422-428.
[27]	[27]SUMIYOSHI T.Possible dose-side effect relationship of antipsychotic drugs:relevance to cognitive function in schizophrenia[J].Expert Rev Clin Pharmacol, 2008, 1 (6) :791-802.
[28]	[28]YOON J S, KIM J M, LEE H, et al.Risperidone use in Korean patients with Alzheimer's disease:optimal dosage and effect on behavioural and psychological symptoms, cognitive function and activities of daily living[J].Hum Psychopharmacol, 2003, 18 (8) :627-633.

Relative Articles(20)

Relative Articles

[1]	Kun LIAN, Yongmei LI, Chenglong SHI, Yilan CHEN, Lei ZHANG, Wei YANG, Xiufeng XU. Exploring Key Mitochondrial Autophagy Genes in Schizophrenia through Integrated Bioinformatics Approaches. Journal of Kunming Medical University, 2024, 46(): 1-13.
[2]	Wensa YIN, Yumei LU, Jinlian TONG, shengjie NIE, Ye RUAN. Research Progress of DNA Methylation and Schizophrenia. Journal of Kunming Medical University, 2023, 44(8): 145-150. doi: 10.12259/j.issn.2095-610X.S20230811
[3]	Tiantian CHENG, Wensa YIN, Jia WANG, Yumei LU, Xuanyu CHEN, Shengjie NIE, Linlin LIU. Association between TMTC1 Gene Polymorphisms and Schizophrenia. Journal of Kunming Medical University, 2023, 44(10): 161-167. doi: 10.12259/j.issn.2095-610X.S20231014
[4]	Meng CHEN, Dingyun YOU, Chenyu XING, Jinman ZHANG, Hongying LI, Zaiqing QU, Bei ZHU. Association between Morning Sickness and Depression in Pregnancy. Journal of Kunming Medical University, 2022, 43(12): 30-35. doi: 10.12259/j.issn.2095-610X.S20221208
[5]	Chaojie ZOU, Yikai TANG, Shuwen DU, Yuqi CHENG. Effects of Modulation of CDC42 Activity in Hippocampal Neurons on Memory and Anxiety Behaviors of Mice. Journal of Kunming Medical University, 2022, 43(11): 1-8. doi: 10.12259/j.issn.2095-610X.S20221105
[6]	Di ZENG, Han-rui SHAO, Ying-ying ZOU, Yong-hua RUAN. Research Progress of Orphan Receptor GPR88 in Related Diseases. Journal of Kunming Medical University, 2021, 42(7): 137-142. doi: 10.12259/j.issn.2095-610X.S20210723
[7]	Feng Zi Qiao , Zhang Yun Qiao , You Xu , Zhang Wen Yu , Long Qing , Teng Zhao Wei , Zeng Yong . . Journal of Kunming Medical University, 2020, 41(05): 150-153.
[8]	Gao Qing , Xie Xing , Luo Li . . Journal of Kunming Medical University, 2020, 41(09): 77-81.
[9]	Wu Jie , Zhang Yun Qiao , Teng Zhao Wei , You Xu , Liu Zi Jun , Ma Yu Han , Zhang Wen Yu , Feng Zi Qiao , Long Qing , Zeng Yong . . Journal of Kunming Medical University, 2019, 40(07): 137-141.
[10]	Liu Chang , Shen Zong Lin , Cheng Yu Qi , Xu Xiu Feng . . Journal of Kunming Medical University, 2019, 40(10): 160-164.
[11]	Jiang Hong Yan , Ran Liu Yi , Wu Gui Xia , Xu Xiu Feng , Yu Li . A Study of Correlation between NDST3 Gene Polymorphism and Schizophrenia Among Han People in Yunnan. Journal of Kunming Medical University, 2018, 39(02): 51-54.
[12]	Lei Jie Peng , Yang Li , Luo Cheng , Zhang Ti Yuan , Lv Xin , Li Sheng Qiao , Lin Hai Bo . Comparative Study of Paliperidone ER Tablets and Risperidone Tablets in Treatment of Childhood and Adolescents First Episode Schizophrenia. Journal of Kunming Medical University, 2017, 38(09): 92-95.
[13]	Feng Guo Hua , Wei Yu Jun , Yuan Jing , Zhang Yan , Zeng Lei , Yang Jian Zhong . . Journal of Kunming Medical University, 2017, 38(05): 50-55.
[14]	Zhu Jun Yan . The Influence of Naikan Therapyon on Depression in Patients with Schizophrenia. Journal of Kunming Medical University,
[15]	Hou Xi . . Journal of Kunming Medical University,
[16]	Ao Lei . . Journal of Kunming Medical University,
[17]	Hou Xi . . Journal of Kunming Medical University,
[18]	Hu Dong Hui . 阿立哌唑与利培酮治疗阿尔茨海默病性痴呆精神症状的临床对照. Journal of Kunming Medical University,
[19]	Liu Ling . . Journal of Kunming Medical University,
[20]	Jiang Yu Hui . . Journal of Kunming Medical University,